Allogene Therapeutics ALLO
NASDAQ ALLO
$1.97 -0.01 (-0.51%)
As of: Sep 4, 2026 · 3:59 PM EDT

Allogene Therapeutics (ALLO) Invested Capital (2018)

Analysis

Allogene Therapeutics (ALLO) Invested Capital (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 33.70 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 7.35 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 6.25 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.13 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.30 Bn
10 Allogene Therapeutics 647.99 Mn 647.99 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 -28.83 Mn